...

Tesamorelin Dosage Calculator

Tesamorelin is an FDA-approved prescription medicine (brand name Egrifta), a growth-hormone-releasing hormone (GHRH) analogue approved to reduce excess abdominal fat in adults with HIV-associated lipodystrophy. This calculator is an educational maths tool, not medical advice. It turns your vial strength, BAC water volume and target dose into a precise draw on a U-100 insulin syringe, so you can check the maths yourself and talk through any dose with your clinician or pharmacy. All dosing information on this page is reference information from the FDA-approved label and common protocol references, and research vials are not the approved product. The worked example used throughout this page is a 5 mg vial mixed with 2 mL of bacteriostatic water. That gives a concentration of 2.5 mg/mL — 2,500 mcg/mL — so a 1 mg dose is 0.4 mL, which is 40 units on a U-100 insulin syringe, and a 2 mg dose is 0.8 mL (80 units). One vial gives five 1 mg doses, or two 2 mg doses with 1 mg left over. A 1 mL syringe holds 100 units, so those 40 units sit at the 40-unit mark on the barrel. The same maths works for any vial strength, from 2 mg to 10 mg: divide the vial strength by the water volume to get the concentration, then divide your target dose by the concentration to get the volume to draw. Tesamorelin acts as a GHRH analogue: it stimulates the pituitary gland to release growth hormone. Its approved use is specific — reducing excess ab

Tesamorelin Reconstitution Calculator

Enter your vial size, bacteriostatic water, and target dose to get an exact syringe draw – with a live visual and a round-unit optimizer so you never eyeball an odd tick mark again.

Your inputs
Select a preset to fill a typical vial size, or set your own below.
mL
Your result
Draw 80 units
0.80 mL on a U-100 insulin syringe
80% of a 1 mL syringe
Concentration
2,500mcg/mL
Mcg per unit
25mcg/unit
Draw volume
0.80mL
Doses per vial
2.5doses

Same three formulas as the homepage calculator: concentration = vial strength divided by BAC water; draw volume = dose divided by concentration; units = draw volume × 100 on a U-100 syringe.

Quick Answers: Tesamorelin Doses in Units

These are the quick answers for the most common example on this page — a 5 mg vial of tesamorelin mixed with 2 mL of BAC water, which gives a concentration of 2.5 mg/mL. Read them off a U-100 insulin syringe, where a 1 mL syringe holds 100 units. This is educational maths, not a dose recommendation; the doses below are the Egrifta label dose (2 mg) and common reference doses, and you should follow the label and your clinician or pharmacy instructions.
Target doseDraw volumeUnits (U-100)
0.5 mg0.2 mL20 units
1 mg0.4 mL40 units
1.4 mg0.56 mL56 units
2 mg0.8 mL80 units
2.5 mg1.0 mL100 units
The 1 mg and 2 mg draws fit in a single 1 mL syringe. The 2.5 mg draw (1.0 mL, 100 units) fills a 1 mL syringe exactly. A 5 mg vial gives five 1 mg doses, or two 2 mg doses with 1 mg left over.

Quick Math Example

Take the 5 mg vial with 2 mL of BAC water as the first example, and the 2 mg vial with 1 mL of BAC water as the second: the first gives 2.5 mg/mL, so 1 mg is 40 units and 2 mg is 80 units; the second gives 2 mg/mL, so 1 mg is 50 units and 2 mg is 100 units — the full vial in one draw. The third example is a 10 mg vial with 2 mL of BAC water: 5 mg/mL, so 1 mg is 20 units and 2 mg is 40 units. The pattern is the same every time: concentration first, then the draw, then the units.

How the Tesamorelin Calculation / Math Works

Step 1 — Find the concentration. Divide the vial strength by the bacteriostatic water volume. A 5 mg vial with 2 mL of water is 5 ÷ 2 = 2.5 mg/mL — that is 2,500 mcg/mL (multiply mg by 1,000 to get mcg: 5 mg is 5,000 mcg), or 25 mcg per unit on a U-100 syringe — because each unit is 0.01 mL, so 2.5 mg/mL × 0.01 mL = 0.025 mg, or 25 mcg. Step 2 — Find the draw volume. Divide the target dose by the concentration to get an exact volume. For a 1 mg dose (1,000 mcg) from a 2.5 mg/mL mix: 1 ÷ 2.5 = 0.4 mL, which is 40 units. A 5 mg vial at a 1 mg dose gives 5 doses. For a 2 mg dose from the same mix: 2 ÷ 2.5 = 0.8 mL, or 80 units. Step 3 — Turn the volume into units. On a U-100 insulin syringe, 1 mL is 100 units, so multiply the draw volume in mL by 100. A 0.4 mL draw is 40 units; a 0.8 mL draw is 80 units; a 1.0 mL draw is 100 units and a 2.0 mL draw is 200 units. The unit markings are in hundredths of a millilitre: 0.01 mL is 1 unit. Small draws are easier to read on a 0.5 mL (50 unit) syringe.

Dosage Formula

Three formulas do all the work. Use them in this order, and keep the units straight (mg for the dose, mL for the water and the draw, mcg only when you need to compare labels).
  • Concentration (mg/mL) = vial mg ÷ BAC water mL. Example: 5 mg ÷ 2 mL = 2.5 mg/mL.
  • Draw volume (mL) = dose mg ÷ concentration (mg/mL). Example: 1 mg ÷ 2.5 mg/mL = 0.4 mL.
  • U-100 units = draw volume (mL) × 100. Example: 0.4 mL × 100 = 40 U-100 units.
On a U-100 insulin syringe the scale is simple: 1 mL is 100 units, so each unit is 0.01 mL. The formulas do not change with the vial size — only the numbers do. A stronger mix gives a smaller draw for the same dose, and a weaker mix gives a larger draw.

Tesamorelin 5 mg Vial with 2 mL Example

This is the reference example for the whole page. Start with the tesamorelin vial: a 5 mg vial + 2 mL of BAC water. The label dose is 2 mg once daily, so work both the 1 mg and the 2 mg draws from the same mix.
  1. Concentration: 5 ÷ 2 = 2.5 mg/mL (2,500 mcg/mL). Written out: 5 mg / 2 mL = 2.5 mg/mL.
  2. Draw volume: the target dose is 1 mg (1,000 mcg), so 1 ÷ 2.5 = 0.4 mL; for 2 mg it is 2 ÷ 2.5 = 0.8 mL.
  3. Units: 0.4 × 100 = 40 U-100 units for 1 mg; 0.8 × 100 = 80 U-100 units for 2 mg. Draw 40 units for 1 mg, or 80 units for 2 mg, on a U-100 syringe.
So: 5 mg in 2 mL gives 2.5 mg/mL, and 1 mg from that mix is 0.4 mL — 40 units. One vial gives five 1 mg doses, or two 2 mg doses with 1 mg left over.

2 mg Vial + 1 mL BAC Water, 1 mg Dose

Take a 1 mg dose from a smaller vial: a 2 mg tesamorelin vial with 1 mL of BAC water. This is the most concentrated of the three examples, and it shows why the vial size matters — the same 1 mg dose is a bigger draw here than from the 5 mg vial.
  1. Concentration: 2 mg / 1 mL = 2 mg/mL (2,000 mcg/mL).
  2. Draw volume: 1,000 mcg / 2,000 mcg per mL = 0.5 mL.
  3. Units: 0.5 mL × 100 = 50 U-100 units.
A 2 mg dose from this mix is 2 ÷ 2 = 1.0 mL — 100 units — which is the entire contents of the vial in a single draw. A 2 mg vial gives two 1 mg doses, or one 2 mg dose.

10 mg Vial + 2 mL BAC Water, 1 mg Dose

Now mix a larger vial with the same water — 10 mg of tesamorelin in 2 mL of BAC water — and take a 1 mg dose. The mix is twice as strong as the 5 mg example, so the draw is half the size.
  1. Concentration: 10 ÷ 2 = 5 mg/mL (5,000 mcg/mL).
  2. Draw volume: 1 ÷ 5 = 0.2 mL.
  3. Units: 0.2 × 100 = 20 units on a U-100 syringe.
From this mix, 2 mg is 0.4 mL — 40 units. A 10 mg vial gives ten 1 mg doses, or five 2 mg doses.

Example Tesamorelin Dosage Table

Always verify your vial label before you draw — this table is for education, and the same dose can be a very different number of units depending on the mix. Check the table against the calculator above before you rely on it.
VialBAC waterConcentrationDoseDrawUnits (U-100)
5 mg2 mL2.5 mg/mL1 mg0.4 mL40 units
5 mg2 mL2.5 mg/mL2 mg0.8 mL80 units
2 mg1 mL2 mg/mL1 mg0.5 mL50 units
2 mg1 mL2 mg/mL2 mg1.0 mL100 units
10 mg2 mL5 mg/mL1 mg0.2 mL20 units
10 mg2 mL5 mg/mL2 mg0.4 mL40 units
Worked from the concentration each time: dose ÷ concentration = draw; draw × 100 = U-100 units. Check your own vial against this table: if it does not match, trust your label and the calculator, not the table.

Choosing BAC Water for a Tesamorelin Vial

There is no single right amount of BAC water: the reconstitution volume sets the strength of the mix, and the right choice depends on the size of the vial and how large the draws are. For a daily dose, a lower concentration gives clearer, more readable unit marks for small doses — but every time the dose changes, re-run the maths for the new dose.
BAC water (5 mg vial)ConcentrationDraw for a 1 mg doseUnits per dose
1 mL5 mg/mL0.2 mL20 units
2 mL2.5 mg/mL0.4 mL40 units
3 mL1.67 mg/mL0.6 mL60 units
2 mL is the practical middle ground for a 5 mg vial: from this mix the reference doses are easy to read — 1 mg is 0.4 mL (40 units) and 2 mg is 0.8 mL (80 units). Less water gives smaller, harder-to-read draws; more water makes the draws larger.

Tesamorelin Dosage Calculator in Units — Dose to U-100 Units Chart

The chart below uses the default water volume on this page: 2 mL of BAC water in a 5 mg vial of tesamorelin (2.5 mg/mL). Each unit is 25 mcg of tesamorelin at this concentration.
DoseDraw volumeUnits (U-100)
0.5 mg0.2 mL20 units
1 mg0.4 mL40 units
1.4 mg0.56 mL56 units
2 mg0.8 mL80 units
2.5 mg1.0 mL100 units
5 mg2.0 mL200 units
Draws above 100 units do not fit a standard 1 mL U-100 insulin syringe (100 units = 1 mL), so for those a larger syringe is needed, or the dose is split across two injections. The 5 mg row (2.0 mL, 200 units) is the full vial in one draw and does not fit a 1 mL syringe.

Tesamorelin Reconstitution Reference — Units per Dose by Vial Size (2 mL BAC Water)

Use 2 mL BAC water throughout this reference. It is reference maths, not a dose recommendation — follow your prescriber’s instructions and the product label.
VialConcentration1 mg1.4 mg2 mg
2 mg1 mg/mL1.0 mL / 100 u1.4 mL / 140 u2.0 mL / 200 u
5 mg2.5 mg/mL0.4 mL / 40 u0.56 mL / 56 u0.8 mL / 80 u
6 mg3 mg/mL0.33 mL / 33 u0.47 mL / 47 u0.67 mL / 67 u
10 mg5 mg/mL0.2 mL / 20 u0.28 mL / 28 u0.4 mL / 40 u
Draws over 1 mL do not fit a standard 1 mL U-100 insulin syringe. The 2 mg vial rows are the weakest mix: a 2 mg dose from a 2 mg vial in 2 mL is the whole vial (2.0 mL) in one draw.

Syringe

Always check the syringe label before you draw. A U-100 insulin syringe is the standard scale: 1 mL is 100 units, so each unit is 0.01 mL. From the standard mix on this page — a 5 mg vial in 2 mL of BAC water (2.5 mg/mL) — a 1 mg dose is 0.4 mL, or 40 units, which sits below halfway up a 1 mL syringe, and a 2 mg dose is 0.8 mL, or 80 units. Draws above 2 mg from this mix need a larger syringe or a split dose. A 0.5 mL (50-unit) syringe is useful for the smallest draws, and a 29–31 gauge needle is typical for this injection. A U-40 syringe gives a different reading — use U-100 only.

Tesamorelin Reconstitution by Vial Size

Tesamorelin is an FDA-approved prescription medicine (Egrifta), and the doses below are label and common reference doses for education — the Egrifta label dose is 2 mg injected subcutaneously once daily, and the current Egrifta F8 formulation is dosed at 1.4 mg daily. The tables give the daily dose in millilitres and U-100 units for each vial size, with 1 mL, 2 mL and 3 mL BAC water. Keep the water at or below 3 mL for a standard vial, and always follow the label and your prescriber’s instructions.

2 mg Vial

A 2 mg vial is the smallest strength on this page and matches the Egrifta label dose in a single vial. At 2 mg/mL (1 mL of water), a 1 mg dose is 50 units and the 2 mg dose is the full vial — 1.0 mL, 100 units — in one draw.
WaterConcentration1 mg1.4 mg2 mg
1 mL2 mg/mL0.5 mL (50 u)0.7 mL (70 u)1.0 mL (100 u)
2 mL1 mg/mL1.0 mL (100 u)1.4 mL (140 u)2.0 mL (200 u)
3 mL0.67 mg/mL1.5 mL (150 u)2.1 mL (210 u)3.0 mL (300 u)

5 mg Vial

The 5 mg vial is the reference example on this page. At 2.5 mg/mL (2 mL of water), a 1 mg dose is 40 units and the 2 mg label dose is 80 units. One vial gives five 1 mg doses, or two 2 mg doses with 1 mg left over.
WaterConcentration1 mg1.4 mg2 mg
1 mL5 mg/mL0.2 mL (20 u)0.28 mL (28 u)0.4 mL (40 u)
2 mL2.5 mg/mL0.4 mL (40 u)0.56 mL (56 u)0.8 mL (80 u)
3 mL1.67 mg/mL0.6 mL (60 u)0.84 mL (84 u)1.2 mL (120 u)

6 mg Vial

A 6 mg vial gives six 1 mg doses, or three 2 mg doses. At 3 mg/mL (2 mL of water), a 1 mg dose is 33 units and a 2 mg dose is 67 units.
WaterConcentration1 mg1.4 mg2 mg
1 mL6 mg/mL0.17 mL (17 u)0.23 mL (23 u)0.33 mL (33 u)
2 mL3 mg/mL0.33 mL (33 u)0.47 mL (47 u)0.67 mL (67 u)
3 mL2 mg/mL0.5 mL (50 u)0.7 mL (70 u)1.0 mL (100 u)

10 mg Vial

A 10 mg vial gives ten 1 mg doses, or five 2 mg doses. At 5 mg/mL (2 mL of water), a 1 mg dose is 20 units and a 2 mg dose is 40 units — the smallest draws on this page, so measure carefully on a 1 mL syringe.
WaterConcentration1 mg1.4 mg2 mg
1 mL10 mg/mL0.1 mL (10 u)0.14 mL (14 u)0.2 mL (20 u)
2 mL5 mg/mL0.2 mL (20 u)0.28 mL (28 u)0.4 mL (40 u)
3 mL3.33 mg/mL0.3 mL (30 u)0.42 mL (42 u)0.6 mL (60 u)

Reconstitution

Reconstitution is simple, but the order matters. Work with clean hands and clean equipment.
  1. Wash your hands. Wipe both vial stoppers with an alcohol swab and let the alcohol dry before you pierce the stopper.
  2. Draw the BAC water volume into a syringe — draw up bacteriostatic water, not plain sterile water — and add it slowly down the inner wall of the vial of lyophilised powder. For example, 2 mL into a 5 mg vial gives 2.5 mg/mL; 2 mL into a 10 mg vial gives 5 mg/mL.
  3. Swirl gently until the powder has dissolved into a clear solution. Do not shake the vial.
  4. Draw the dose with a 100-unit insulin syringe (1 mL U-100). From the 2.5 mg/mL mix (5 mg vial in 2 mL of water), 1 mg is 40 units and 2 mg is 80 units.
  5. Choose an injection site — abdomen, outer thigh, or upper arm — pinch a skin fold, insert the needle at a 45 to 90 degree angle, inject slowly, and hold for 5 seconds before withdrawing. Use a 29 to 31 gauge needle and a new sterile syringe for every injection.

Storage

Store reconstituted tesamorelin in a refrigerator at 2–8 °C (36–46 °F). Do not freeze it: freezing can damage the peptide, and a vial that has frozen should be discarded — never try to thaw and re-use it. Keep the vial upright in its box or another dark place so it is protected from light, and keep it out of reach of children and pets. Once mixed, use the vial within about 4 weeks. Write the mixing date and the discard date on the label so you can check at a glance — for example, a vial mixed on the 1st of the month should be finished by about the 29th. Do not leave a mixed vial at room temperature for long periods, and do not store it in the freezer or in a car. If the solution looks cloudy or contains particles, do not use it. This is educational information only, not medical advice; when in doubt, ask a pharmacist.

Dosing Schedule

Tesamorelin is an FDA-approved prescription medicine, and the doses on this page are label and common reference doses for education — the Egrifta label dose is 2 mg injected subcutaneously once daily, and the current Egrifta F8 formulation is dosed at 1.4 mg daily. Your prescriber decides the dose and timing; this page shows the reference doses so you can see how the maths changes with the dose. The injection is once daily. Protocol references commonly describe tesamorelin as taken once daily, often before bed or on an empty stomach — that timing is a protocol reference, not a label instruction. If you miss a dose, follow the instructions in the label and your prescriber’s instructions. The dose is daily, not weekly.
ReferenceDoseWhen
Label dose (Egrifta, original formulation)2 mg once dailyDaily, by subcutaneous injection
Egrifta F8 (current formulation)1.4 mg once dailyDaily, by subcutaneous injection
Common research / reference range1–2 mg once dailyDaily (protocol references commonly describe use before bed or on an empty stomach)
The dose is daily, not weekly. Do not change a prescribed dose or timing without your prescriber’s instruction, and always follow the label and your prescriber’s instructions.

What You Need

To reconstitute a vial of tesamorelin you need the following:
  • A vial of lyophilised tesamorelin powder.
  • Bacteriostatic water (BAC water) — 0.9% benzyl alcohol in sterile water.
  • A 1 mL U-100 insulin syringe (100 units).
  • Alcohol swabs.
  • A sharps container.
A sterile mixing syringe and needle are also useful for drawing up the BAC water. Never use tap water, and never reuse a needle or syringe — use a new sterile syringe for every draw and put used sharps straight into a sharps container. The approved Egrifta product is a lyophilised powder kit with its own reconstitution instructions in the label — for Egrifta, follow those. This is educational only.

Comparing Options

Tesamorelin, sermorelin and ipamorelin are all peptides that act on the growth hormone axis, but they work differently and their regulatory status is very different. The comparison below is informational only.
PeptideHow it worksStatus
TesamorelinGHRH analogue — stimulates the pituitary to release growth hormoneFDA-approved (Egrifta, for HIV-associated lipodystrophy)
SermorelinGHRH fragment analogue — a fragment of GHRH that stimulates growth hormone releaseFormerly FDA-approved (Geref); no longer marketed in the US
IpamorelinGhrelin mimetic / growth hormone secretagogueInvestigational — not FDA-approved
Tesamorelin is the only one of the three with a current FDA approval, and that approval is specific: reducing excess abdominal fat in adults with HIV-associated lipodystrophy (Egrifta). Sermorelin and ipamorelin are not approved products. This comparison is informational only and is not medical advice.

What Is Tesamorelin?

Tesamorelin is a synthetic growth-hormone-releasing hormone (GHRH) analogue: it mimics the body’s own GHRH and stimulates the pituitary gland to release growth hormone. It is sold as the prescription medicine Egrifta. Tesamorelin was approved by the FDA as Egrifta to reduce excess abdominal fat in adults with HIV-associated lipodystrophy. That approval is for that specific condition — it is not a general weight-loss approval — and the label dose is 2 mg injected subcutaneously once daily (the current Egrifta F8 formulation is dosed at 1.4 mg daily). Tesamorelin differs from sermorelin in its structure: tesamorelin is a GHRH analogue, while sermorelin is a GHRH fragment analogue — a shorter fragment of the GHRH molecule. Both stimulate growth hormone release, but they are different molecules with different histories and regulatory status. Research vials sold online are not the approved Egrifta product.

Sources/References

The dose figures and product information on this page are drawn from the following sources:
  1. Egrifta (tesamorelin) Prescribing Information, Theratechnologies — FDA-approved label. Label dose 2 mg injected subcutaneously once daily; the current Egrifta F8 formulation is dosed at 1.4 mg daily. Approved to reduce excess abdominal fat in adults with HIV-associated lipodystrophy.
  2. FDA approval information for Egrifta (tesamorelin) — FDA-approved prescription medicine for HIV-associated lipodystrophy.
  3. Common protocol references for tesamorelin research use — reference dose range 1–2 mg daily, commonly described as taken once daily before bed or on an empty stomach.
All calculations on this page were worked from the standard formula — concentration = vial strength divided by BAC water; draw volume = dose divided by concentration; units = draw volume × 100 on a U-100 syringe — and checked against the calculator above.

FAQ

How many units is 1 mg of tesamorelin? For the standard mix on this page — a 5 mg vial in 2 mL of BAC water (2.5 mg/mL) — 1 mg is 0.4 mL, which is 40 units on a U-100 syringe. Each unit is 25 mcg of tesamorelin at that concentration. How many units is 2 mg of tesamorelin? From the same standard mix (5 mg in 2 mL of BAC water, 2.5 mg/mL), 2 mg is 0.8 mL, which is 80 units on a U-100 syringe. That is the Egrifta label dose. How much BAC water do I add to a 5 mg tesamorelin vial? There is no single amount: 2 mL is the standard example on this page, and the “Reconstitution by Vial Size” section shows 1 mL, 2 mL and 3 mL. With 2 mL, a 5 mg vial gives 2.5 mg/mL, so 1 mg is 40 units and 2 mg is 80 units. Which syringe do I use? A 1 mL U-100 insulin syringe (100 units), usually 29–31 gauge. Always check the syringe label — a U-100 syringe has 100 units per 1 mL. A U-40 syringe reads differently, so do not use one for a U-100 dose. When is tesamorelin taken? The Egrifta label dose is 2 mg injected subcutaneously once daily. Protocol references commonly describe tesamorelin as taken once daily, often before bed or on an empty stomach — that timing is a protocol reference, not a label instruction. Follow the label and your prescriber’s instructions. Is tesamorelin FDA approved? Yes. Tesamorelin is FDA-approved as Egrifta, a prescription medicine to reduce excess abdominal fat in adults with HIV-associated lipodystrophy. Research vials are not the approved product. How do I store tesamorelin? Refrigerate reconstituted tesamorelin at 2–8 °C (36–46 °F), do not freeze it, protect it from light, and use it within about 4 weeks of mixing.
Scroll to Top